Skip to main content

Primidone

NDC 53746-545 · Amneal Pharmaceuticals of New York LLC

Generic namePrimidone
Dosage formTABLET
RouteORAL
Active ingredient(s)PRIMIDONE
Strength250 mg/1
Pharmacologic classAnti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

53746-545-01 — 100 TABLET in 1 BOTTLE (53746-545-01)

53746-545-05 — 500 TABLET in 1 BOTTLE (53746-545-05)

53746-545-10 — 1000 TABLET in 1 BOTTLE (53746-545-10)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0591-5321 — Primidone, 0615-8206 — Primidone, 42291-509 — Primidone, 42291-511 — Primidone, 50268-686 — Primidone, 50268-687 — Primidone, 51407-637 — Primidone, 51407-638 — Primidone, 52817-117 — Primidone, 53746-544 — Primidone, 55111-476 — Primidone, 55111-477 — Primidone, 62135-468 — Primidone, 63629-7811 — Primidone, 65162-544 — Primidone, 65162-545 — Primidone, 66490-690 — Primidone, 66490-691 — Primidone, 68084-202 — Primidone, 68084-203 — Primidone, +20 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels